Clinical Research Facility

Gilroy, California 95020

We've found

1 trials

at this facility

Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma

Status: Enrolling, Phase
Updated: 12/31/1969

from

Gilroy, CA

Use our guide to learn which trials are right for you!